Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Strong
Garp
Strong
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Very Strong
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Website
Zevra Therapeutics, Inc.
Telephone
1.888.958.1253
Address
29th Floor, 101 Federal Street, Boston, FL 34747
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 7.16 - 13.16
Trade Value (12mth)
US$3,187,835.00
1 week
-7.36%
1 month
-1.83%
YTD
22.3%
1 year
17.78%
All time high
418.40
EPS 3 yr Growth
-280.70%
EBITDA Margin
-0.20%
Operating Cashflow
-$2m
Free Cash Flow Return
-1.00%
ROIC
49.00%
Interest Coverage
0.00
Quick Ratio
5.60
Shares Outstanding (Fully Diluted)
60m
HALO Sector
Healthcare
Next Company Report Date
10-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 07 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 10 March 26 | |
| 10 March 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.3 | -2.28 | 1.4 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.3 | -2.28 | 1.35 | | | | ||
Growth | % | | | | | -67.3 | -75.6 | 161.5 | | | | ||
PE | X | | | | | N/A | N/A | 6.6 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
